Health
IBM uses AI to evaluate risk of developing genetic diseases – VentureBeat
In a Nature Communications study, researchers at IBM, the Broad Institute, and Color find genetic mutations aren’t always useful predictors of disease.
In a study published in the journal Nature Communications, scientists at IBM, the Broad Institute of MIT and Harvard, and health tech company Color detail evidence that the presence of genetic mutations isnt a reliable precursor to genetic diseases. They claim diseases can be so greatly influenced by other factors that the risk in carriers is sometimes as low as in that in noncarriers.
The research which stems from a larger, three-year collaboration between IBM Research and the Broad Institute …
Continue Reading
